In vivo, MSC-exo reduced MI size by up-regulating autophagy through the AMPK/mTOR and Akt/mTOR pathways, which consequently led to an up-regulated expression of myocardial LC3B and improved cardiac function. This evidence concerns the gene MTOR and myocardial infarction.